TORONTO -- (Marketwire) -- 09/02/08 -- BellwetherReport.com is the leading online financial newsletter for investors seeking top independent and unbiased research. Investors seeking free and unbiased analyst opinions on the companies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports. Today, we have once again scheduled interviews with a number of the top analysts in North America to get an update feedback from them regarding the current market activity and position Sciele Pharma Inc. (NASDAQ: SCRX), Atherogenics Inc. (NASDAQ: AGIX), Bucyrus International Inc. (NASDAQ: BUCY) and Intersil Corporation (NASDAQ: ISIL).
To receive free access to these interviews and analyst reports sign up to www.bellwetherreport.com by clicking this link. These reports may also be updated reports so you will be able to access the past reports as on the above mentioned companies as well.
All small-cap investors be sure to sign up to our Bellwether Report Small-Cap Newsletter.
*Please note that analyst reports are conducted daily and immediate sign up is crucial to your success when using these reports*
All analyst reviews will be posted for free under "today's articles" within 24 to 48 hours of the interview being completed.
Each interview will vary and may include, but will not be limited to the following:
-- An Unbiased View of the Company -- Short-term Target Prices -- Long-term Resistance and Support Levels -- Analyst Opinions -- Sector Review -- Competition Overview -- Direct Market Integration and Influence
Investors looking to access these interviews are encouraged to sign up now at http://www.bellwetherreport.com/home/registration.php.
Members are also given the opportunity to receive a free "custom stock review" on any equities you currently hold in your portfolio. Simply sign up, and in the members section of www.bellwetherreport.com, you can ask an analyst for his or her opinion of any stocks you currently have in your portfolio by filling out the form under the tab "custom stock review."
Bellwether Report is not affiliated or compensated by any of the above mentioned companies, nor do we own a position in any of the companies.